Skip to main content
GOV.UK
Blog: MedRegs
Organisations:
Medicines and Healthcare products Regulatory Agency

Behind the scenes of: a Licensing Division Delivery Manager

Posted by: Paul Cottingham, Posted on: 31 January 2017 - Categories: Behind the Scenes

The Regulatory Information Service (RIS) was formed in 2006 to act as a main point of contact for industry and their representatives for a range of enquiries - from simple administrative queries right through to complex regulatory queries - and …

Read more of Behind the scenes of: a Licensing Division Delivery Manager

Our new 'Variation Fees Calculator'

Posted by: Paul Cottingham, Posted on: 11 January 2017 - Categories: Variations
Abacus - copyright: junce

A variation allows the applicant to apply for changes to a marketing authorisation.  Changes are classed either as minor changes which include Type 1A or Type 1B variations, or as a major change classed as a Type II.

Read more of Our new 'Variation Fees Calculator' - 2 comments

Help with Type 1B variations

Posted by: Julia Coombes, Posted on: 10 January 2017 - Categories: Variations

The Product Information Quality Unit (PIQU) team often gets asked for help during a Type 1B variation procedure. This ranges from providing advice on missing documents to explaining why the proposed changes are not acceptable first time around.

Read more of Help with Type 1B variations

Welcome to the MedRegs Blog

Posted by: Siu Ping Lam, Posted on: 9 January 2017 - Categories: From the Top
https://youtu.be/DBX5ZmOWbbQ

If you’re working to develop and submit applications to MHRA for marketing authorisations and clinical trial authorisations, then you need to keep up to date with the latest regulatory thinking and be able to easily find tips and tricks to avoid common pitfalls.

Read more of Welcome to the MedRegs Blog

Related content and links

MedRegs Blog

An official blog of the Medicines and Healthcare products Regulatory Agency (MHRA), providing expert insight on the latest regulatory thinking and all aspects of medicines regulation.

Find out more.

Categories

  • AI Airlock
  • AI Commission
  • antimicrobial resistance (AMR)
  • Behind the Scenes
  • Biological Medicines
  • Clinical Trials
  • Conferences and events
  • Decentralised Manufacturing
  • designated standards
  • Diagnostics
  • eCTD
  • From the Top
  • Good Clinical Practice
  • Good Manufacturing Practice
  • Health Institution Exemption
  • Health Institution Exemption (HIE)
  • ILAP
  • IMDRF
  • Improving Our Services
  • Innovation
  • IVD
  • Life Sciences
  • Med Tech Regulations
  • Medical Devices
  • Medicines in pregnancy
  • Medicines Packaging
  • Model informed Drug development (MIDD)
  • Patient involvement
  • Post-Market Surveillance
  • Pre-market statutory instrument
  • TDP
  • Uncategorized
  • Variations
  • WHO
  • World Patient Safety Day

Sign up and manage updates

  • Email
  • Atom

Follow us

  • MHRA on Twitter
  • MHRA Medicines Twitter
  • MHRA on LinkedIn
  • MHRA on Facebook

Other MHRA Blogs

MHRA Inspectorate

Recent Posts

  • Route B substantial modifications: find out how the pilot was received
  • Shaping the future of healthcare
  • The new ILAP TDP: De-risking development by bringing early insights, predictability and improved coordination for developers
  • 2025 in MedTech: a year of innovation, global leadership and regulatory milestones
  • Innovative approaches to Med Tech regulatory reform

Recent Comments

  • Sarah-Rose Burke on Getting it Right First Time
  • Beena Shaikh on Getting it Right First Time
  • sarahroseburke on When the unexpected happens: Batch Specific Variations
  • sarahroseburke on Our new 'Variation Fees Calculator'
  • Stefan on Our new 'Variation Fees Calculator'

Archives

  • April 2026
  • March 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • April 2024
  • March 2024
  • February 2024
  • November 2023
  • October 2023
  • September 2023
  • April 2023
  • March 2023
  • December 2022
  • October 2022
  • August 2022
  • May 2022
  • January 2022
  • December 2021
  • August 2021
  • May 2021
  • October 2020
  • September 2020
  • June 2020
  • March 2020
  • December 2019
  • June 2019
  • May 2019
  • March 2019
  • October 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • October 2017
  • August 2017
  • July 2017
  • April 2017
  • February 2017
  • January 2017

Categories

  • AI Airlock
  • AI Commission
  • antimicrobial resistance (AMR)
  • Behind the Scenes
  • Biological Medicines
  • Clinical Trials
  • Conferences and events
  • Decentralised Manufacturing
  • designated standards
  • Diagnostics
  • eCTD
  • From the Top
  • Good Clinical Practice
  • Good Manufacturing Practice
  • Health Institution Exemption
  • Health Institution Exemption (HIE)
  • ILAP
  • IMDRF
  • Improving Our Services
  • Innovation
  • IVD
  • Life Sciences
  • Med Tech Regulations
  • Medical Devices
  • Medicines in pregnancy
  • Medicines Packaging
  • Model informed Drug development (MIDD)
  • Patient involvement
  • Post-Market Surveillance
  • Pre-market statutory instrument
  • TDP
  • Uncategorized
  • Variations
  • WHO
  • World Patient Safety Day

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Comments and moderation

Read our guidelines

Useful links

  • All GOV.UK blogs
  • All GOV.UK blog posts
  • GOV.UK
  • All departments
  • Accessibility statement
  • Cookies
All content is available under the Open Government Licence v3.0, except where otherwise stated
© Crown copyright